Vitamin K2 for adults with episodic migraine
Part of Blood & lymphatic, Brain & nervous system, Hormones & metabolism clinical trials.
This trial tests whether taking vitamin K2 can reduce the number of migraine days per month. It may help people who have had episodic migraines for at least a year and meet specific migraine frequency and medication requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re an adult (18 years or older).
- You’ve had episodic migraine (with or without “aura”) for more than 12 months.
- In the last 3 months, you’ve had 4 to 14 migraine days per month, and this is confirmed during the study’s baseline period.
- You kept your migraine diary successfully during the baseline period.
- You are NOT currently taking migraine prevention medicines (like valproate, topiramate, beta-blockers, and others listed), and you haven’t taken them in the last 3 months.
- You can’t have certain other headache types mixed in, and you must avoid frequent migraine/stopping medicines and some other drugs (including triptans/ergot too often, high-use pain relievers, opioids, and anticoagulants).
- You can’t be pregnant or breastfeeding, and you must be able to take pills by mouth; also no vitamin K2 allergy and no known problems absorbing food.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a combination of vitamins and supplements can help prevent migraines. It's for adults who have migraines often (at least 6 days per month) and want to try a non-drug option.
This trial studies whether vitamin K2 can help people with chronic kidney disease (kidney damage that lasts months or longer), especially those with higher protein levels in the urine. It compares vitamin K2 use in a specific group and watches kidney-related health outcomes and safety.
This trial tests whether a daily dose of atorvastatin (a common cholesterol medicine) can prevent migraine attacks in people with episodic migraine. You would keep a headache diary and be randomly assigned to take atorvastatin or a placebo for about 3 months.
This study tests whether taking vitamin K2 can help people with low bone density (osteopenia or osteoporosis) who have a specific change in the VDR gene. If you have this gene change, vitamin K2 may work better for you than standard supplements.
This trial tests whether the cholesterol drug atorvastatin can reduce the number of migraine days in people with chronic migraine (15 or more headache days per month, including at least 8 migraine days). If you have frequent migraines and haven't tried statins before, this study may offer a new preventive option.
This study tests whether taking vitamin D3 and K2 supplements can improve health in military healthcare workers who have low vitamin D levels. If you qualify, you will stop any current vitamin D or K supplements and take the study supplement for 4.5 months.
Hear when a new Arterial Stiffness trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.